Showing posts with label drug news. Show all posts
Showing posts with label drug news. Show all posts

Saturday, July 18, 2015

Psychedelic Microdosing: The Good, the Bad and the Ugly - http://clapway.com/2015/07/18/psychedelic-microdosing-the-good-the-bad-and-the-ugly-234/

A lesser-known but increasingly popular phenomenon is fascinating “psychonauts” and puzzling researchers: psychedelic microdosing. This new way of doing psychedelic drugs involves routinely taking a small fraction of a normal dose of lysergic acid diethylamide (LSD) or magic mushrooms, LiveScience explained.


Supporters of psychedelic microdosing report improvements in perception, creativity, mood and concentration skills, minus the “trippy” flying elephants normally associated with psychedelics. Yet microdosing remains uncharted territory and the side effects are still unknown.


A new way of taking psychedelics?


Psychedelic Microdosing: The Good, the Bad and the Ugly - ClapwayIn a recently published in-depth post on the High Existence blog Martijn Schirp, a former poker player and recent graduate in interdisciplinary science in Amsterdam, described his own adventure in psychedelic microdosing.


Schirp believes that this manner of taking psychedelics, also known as a psycholytic dose, “is much easier integrated into non-psychedelic activities”. He added that it offers a way to “get a taste” without getting completely wasted. “It’s like the coffee to wake up the mind-body connection.”


Yet even Schirp admitted that the experience was not always positive: “At times, the experience was still too overwhelming to be productive—I just wanted to lay down or take a walk,” he said.


Underground research on LSD and psychedelic microdosing


Psychedelic Microdosing: The Good, the Bad and the Ugly - ClapwaySchirp first became interested in the “potential of microdosing psychedelics” after reading about James Fadiman, a psychologist and researcher at Sofia University in Palo Alto, California, and his life’s work.


In his book The Psychedelic Explorer’s Guide, Fadiman addressed in details the practice and came to the conclusion that “micro-dosing turns out to be a totally different world.”


Since research with LSD remains banned, Fadiman relied on a group of volunteers who would send him details of their doses and daily routines by email. Study participants functioned normally in their work and relationships, Fadiman found, but with increased focus, emotional clarity, and creativity.


The idea of taking small doses of psychedelics is not completely new. The inventor of LSD, Dr. Albert Hofmann, was known to microdose in his old age. He said in an interview, however, that his first “trip” with the psychedelic was crushing and that “the unpredictability of effects is the major danger of LSD.”


“My first planned self-experiment with LSD was a “bum trip” as one would say nowadays,” he said, adding that if the use of the drug were at present legal, which is not the case, then is would be “handled best by a ripe, stabilized person with a meaningful reason for taking LSD”.


Psychedelic Microdosing and doping


James Oroc, the author of the book ‘Tryptamine Palace: 5-MeO-DMT and the Sonoran Desert Toad’, extensively wrote about the correlation between psychedelics and extreme sports, arguing that microdosing reportedly improves both stamina and abilities in athletes.


A report by the Cycling Independent Reform Commission (CIRC) looked at the problem of doping in professional cycling, focusing in particular on how some riders are now microdoping to stay within the limits of the Biological Passport.


Long-term side effects of psychedelics


According to Matt Johnson, a psychologist at Johns Hopkins University in Baltimore, Maryland, the long-term side effects of regularly taking small doses of psychedelics are still unknown. Johnson, who has studied the behavioral effects of psychedelic drugs, told LiveScience that although smaller doses of psychedelic are safer than larger ones, microdosing could hide serious dangers.


“Still, there’s absolutely no evidence to suggest microdosing works as people claim it does”, Johnson said. Johnson noted that because of LSD’s illegality there is no way for users to know exactly what they are getting from the black market or dark web. In addition, people react differently to psychedelic drugs.


“Someone might be expecting a kind of sparkly day, just a really productive day at work — and next thing you know, they’re grasping hold to their office chair wondering why the world is dissolving,” he said.


LSD use in the U.S.


According to the latest National Survey on Drug Use and Health, 229,000 Americans ages 12 and older reported current (past-month) use of LSD. Reports show that while regular use of hallucinogenic and dissociative drugs in general has remained relatively low in recent years, the United States ranks first among 36 nations in the proportion of high school students ever using LSD or other hallucinogens in their lifetime.


Is psychedelic microdosing more dangerous than what some claim? Share your opinion in the comments section below.



 


Clapway Trends has more tech related news:




Psychedelic Microdosing: The Good, the Bad and the Ugly

Sunday, June 28, 2015

After reading this, you"ll think "what"s a little mj?" - http://clapway.com/2015/06/28/poppy-plants-close-to-be-home-brewed-drawing-thin-line-between-science-and-crime-223/

For centuries, poppy plants were grown in some remote fields well hidden in Afghanistan’s topography, thanks to a group of scientists, this may soon change.


The last gene in the quest to lab-engineer opiates such as morphine was finally identified. Some fear that the scientific breakthrough could perhaps be a double-edged sword, helping drug traffickers produce “Brown Sugar” in their backyards.


THE THIN LINE BETWEEN SCIENCE AND CRIME


About a month ago, researchers and policymakers started fussing about a frightening scenario for drug enforcement: the possibility of aficionados “home brewing” narcotics such as the highly addictive opiates. Well, we now know that this could happen sooner than predicted.


Researchers in the UK and Australia announced that they have discovered one of the most sought-after genes in poppies that could help scientists engineering morphine-making yeast to manufacture painkillers and other poppy-derived compounds.


THE LAST ELEMENT OF THE GENE SEQUENCE


Scientists have finally determined the last ‘ingredient’ playing a major role in the synthesis of the morphine class of alkaloids, which include the “most effective painkillers known to man,” according to lead researcher Professor Ian Graham.


The gene, called STORR, was the ultimate element of the sequence, which may now be used by researchers to coax opiate production from microbes such as yeast. STORR’s discovery was recently detailed in a new paper published in the journal ‘Science’.


MIXED REACTIONS


People have grown poppy plants to produce pain relief drugs for thousands of years, generating global prescription sales of around 12 billion US dollars annually.


While the scientific (and pharmaceutical) community is thrilled about the new discovery, law enforcement authorities foretell the risk of people starting to illegally produce opiate on their own.


The potential exploitation of this technology could result in drug dealers developing narcotics as easily as brewers now craft their own cider.


What if a small garden of poppy plants in someone’s backyard starts feeding the growing appetite for heroin across the globe?


OPIUM PRODUCTION AND TRAFFICKING


According to the latest annual World Drug Report published by the United Office on Drugs and Crime (UNOCD) on Friday, illegal opium production occupies more land worldwide than ever before. Overall, global opium poppy cultivation in 2014 reached the highest level since the late 1930s. This is largely because of a surge in cultivation in Afghanistan, the dominant opium producer.


Although the destination of the additional quantities of drugs such as heroin is unclear, there are signs of change in the supply chain, underlining the fact that “the reach of organized criminal networks continues to be global and that organized criminal groups are becoming increasingly sophisticated and versatile.”


CONSUMPTION OF POPPY-DERIVED DRUGS


While data indicate that the use of heroin and opium has remained stable at the global level, the abuse of pharmaceutical opioids has continued to rise.


Some 32.4 million people – or 0.7 per cent of the world’s adult population – are users of poppy-derived drugs, with women being reportedly more likely to misuse pharmaceutical prescriptions.


POSSIBLE FUTURE SCENARIOS


The UN Secretary-General Ban Ki-moon urged the international community to focuses on alternative development; a long-term strategy aimed at coming up with substitute sources of income for farmers dependent on illicit drug cultivation.


As science is one step closer to producing poppy plants in labs, there are a number of scenarios that could unravel. Number one: the technology will remain within the scientific community, generating potential life-saving drugs. Number two: governments across the globe will consequently be encouraged to come up with alternative employment opportunities for all the farmers involved in opium production. Number three: drug dealers, even the “small fishes” in this big pound, will start growing their own poppy plants resulting in increased narcotics supply and easier access to the international illegal drug market.



 


For nature in your own house, check out Atmoph:




Poppy Plants Close to Be "Home Brewed", Drawing Thin Line Between Science and Crime